MedPath

Implication of Left veNtricle Vortex Flow Guided aNticOagulation Therapy for preVenting Apical Thrombus Formation In Patients With Acute myOcardial infarctioN: Multicenter Prospective Randomized Clinical Trial; INNOVATION Study

Completed
Conditions
Apical Thrombus Formation
Acute Myocardial Infarction
Registration Number
NCT01869998
Lead Sponsor
Yonsei University
Brief Summary

Implication of left veNtricle vortex flow guided aNticOagulation therapy for preVenting Apical Thrombus formation In patients with acute myOcardial infarctioN: Multicenter Prospective Randomized Clinical Trial; INNOVATION study

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
111
Inclusion Criteria
  1. Patient is ≥ 30 years old
  2. Acute anterior wall myocardial infarction showing akinetic or dyskinetic apical wall motion abnormalities on an initial transthoracic echocardiogram
  3. Left ventricular ejection fraction less than 40%
Read More
Exclusion Criteria
  1. Prior history of myocardial infarction
  2. Chronic medication with Coumadin
  3. Contraindication of contrast echocardiography
  4. Significant atrial or ventricular arrhythmia
  5. Valvular heart disease more than moderate degree
  6. Decompensated heart failure
  7. Very poor echo window, which cannot evaluate the presence of apical thrombus
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Apical thrombus formation in echocardiography30 days after initial echocardiography

Evaluate and compare the incidence of thrombus formation in high risk group (Vortex depth \< 0.45) and low risk group (Vortex Depth ≥ 0.45)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Severance cardiovascular hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath